Investigation of new candidate genes in a cohort of patients with familial congenital hypopituitarism and associated disorders

作者: LC Gregory

DOI:

关键词:

摘要: Congenital hypopituitarism is a complex variable genetic disorder that known to be caused by multiple mutated genes, both in isolation and variably penetrant cases of digenic inheritance. In only <10% cases, mutation causative gene has been identified the patient, leaving vast majority patients yet have detected responsible for pathogenicity functional significance their condition. This study investigates novel genes pathways involved hypothalamo-pituitary development. Our large cohort consanguineous non-consanguineous pedigrees with disease are routinely screened variants genes. where there no these particular exome sequencing collaboration GOSgene carried out uncover regions interest abnormal individual. Upon identification any variant or assays conducted further show change. Firstly this identifies first homozygous LHX4 gene, p.T126M, two deceased brothers from pedigree combined pituitary hormone deficiency subsequent fatal consequences. Functional luciferase showed was significant difference between mutant p.T126M WT constructs transactivating αGSU prolactin promoters, could synergise POU1F1 similar LHX4. Secondly, six new candidate genes; CTPS2, RNPC3, PRMT6, FASN, APEX2 EIF2S3, were phenotypically unique submitted sequencing. The human embryonic expression profiles analysed context, as well related tissues affected individuals. Thirdly, role eIF2γ, encoded which found an X-linked congenital hypopituitarism, hypothyroidism hyperinsulinism causing hypoglycaemia, investigated study. A lentiviral shRNA knock EIF2S3 pancreatic cells resulted significantly higher apoptosis compared cells. used Sanger approach identify respectively.

参考文章(249)
Randall W. Whitcomb, William F. Crowley, Male hypogonadotropic hypogonadism. Endocrinology and Metabolism Clinics of North America. ,vol. 22, pp. 125- 143 ,(1993) , 10.1016/S0889-8529(18)30183-X
S.S. Li, H., Witte, D.P., Branford, B.W., Aronow, B.J., Weinstein, M., Kaur, S., Wert, S., Singh, G., Schreiner, C.M., Whitsett, J.A., Scott, W.J. and Potter, Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. The EMBO Journal. ,vol. 13, pp. 2876- 2885 ,(1994) , 10.1002/J.1460-2075.1994.TB06582.X
Mehul T Dattani, Rodrigo E Bancalari, Mark J McCabe, Diagnosis and evaluation of hypogonadism. Pediatric endocrinology reviews. pp. 214- ,(2014)
Stephanie C. Colvin, Roland W. Pfaeffle, Rachel D. Mullen, Simon J. Rhodes, LHX3 and LHX4 transcription factors in pituitary development and disease. Pediatric endocrinology reviews. ,vol. 6, pp. 283- 290 ,(2009)
Antti Kauppila, Hannu Martikainen, Ulla Puistola, Matti Reinilä, Lars Rönnberg, Hypoprolactinemia and ovarian function. Fertility and Sterility. ,vol. 49, pp. 437- 441 ,(1988) , 10.1016/S0015-0282(16)59769-6
Pauline C. Ng, Ewen F. Kirkness, Whole Genome Sequencing Methods in Molecular Biology. ,vol. 628, pp. 215- 226 ,(2010) , 10.1007/978-1-60327-367-1_12
Mark J. McCabe, Mehul T. Dattani, Genetic aspects of hypothalamic and pituitary gland development. Handbook of Clinical Neurology. ,vol. 124, pp. 3- 15 ,(2014) , 10.1016/B978-0-444-59602-4.00001-0
Andrea Flynn, Christopher G. Proud, The role of eIF4 in cell proliferation. Cancer surveys. ,vol. 27, pp. 293- 310 ,(1996)
Robin C. C. Ryther, Lindsay M. McGuinness, John A. Phillips, Chanda T. Moseley, Charalambos B. Magoulas, Iain C. A. F. Robinson, James G. Patton, Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II. Human Genetics. ,vol. 113, pp. 140- 148 ,(2003) , 10.1007/S00439-003-0949-X
Zahra Kashi, Ozra Akha, Adele Bahar, Zakiie Vesgari, HYPERPROLACTINEMIA IN ASSOCIATION WITH SUBCLINICAL HYPOTHYROIDISM caspian journal of internal medicine. ,vol. 2, pp. 229- 233 ,(2011)